RE:RE:RE:Still not looking to buy" we believe 2021 has the potential to continue the growth of our Company as we further expand production at Kainantu, significantly ramp-up exploration on multiple vein and porphyry targets, and complete our next resource update and Stage 3 Definitive Feasibility Study in the second half of 2020. We believe the future for Kainantu and K92 looks very exciting.